SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Avon Products Inc – ‘8-K’ for 5/16/19

On:  Friday, 5/17/19, at 5:17pm ET   ·   For:  5/16/19   ·   Accession #:  950157-19-609   ·   File #:  1-04881

Previous ‘8-K’:  ‘8-K/A’ on 5/3/19 for 5/2/19   ·   Next:  ‘8-K’ on / for 5/22/19   ·   Latest:  ‘8-K’ on 8/8/23 for 8/7/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/17/19  Avon Products Inc                 8-K:5,9     5/16/19    2:220K                                   Cravath Swaine & … 01/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     30K 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML    135K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM 8-K



CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 16, 2019



Avon Products, Inc.
(Exact name of registrant as specified in charter)



New York
   
13-0544597
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)

Building 6, Chiswick Park
London W4 5HR
United Kingdom

(Address of principal executive offices) (Zip Code)

+44-1604-232425

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:



Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, par value $0.25 per share
AVP
NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐






Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

At the 2019 Annual Meeting of Shareholders (the “2019 Annual Meeting”) of Avon Products, Inc. (the “Company”) held on May 16, 2019, the Company’s shareholders, upon the recommendation of the Board of Directors, approved the Avon Products, Inc. 2016 Omnibus Incentive Plan (Amended and Restated Effective May 16, 2019) (the “Plan”).  Amongst other non-material changes, the amendment to the Plan authorized an additional 5,000,000 shares for issuance under the Plan.  A more detailed summary of the Plan can be found in the Company’s Proxy Statement for the 2019 Annual Meeting filed with the Securities and Exchange Commission on April 2, 2019 (the “Proxy Statement”). The foregoing and the summary in the Proxy Statement are not complete summaries of the terms of the Plan and are qualified by reference to the text of the Plan, which is filed herewith as Exhibit 10.1 and incorporated herein by reference.

Item 5.03
 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On May 16, 2019, the Board of Directors of the Company approved an amendment to the Company’s by-laws that would allow former employees who have never served as the Chief Executive Officer of the Company and have not been an employee of the company in the past five years to serve on the Company’s standing Committees. A copy of the by-laws are attached to this Form 8-K as Exhibit 3.1.




Item 5.07
Submission of Matters to a Vote of Security Holders.

The 2019 Annual Meeting of the Company was held on May 16, 2019.  The final results of voting on each of the matters submitted to a vote of shareholders at the 2019 Annual Meeting are set forth below.

1. Each of the director nominees listed below was elected for a one-year term expiring in 2020:
 
     
Votes For
 
Withheld
 
Broker
Non-Votes
 
Jose Armario
 
383,276,907
 
1,615,101
 
77,341,177
 
W. Don Cornwell
 
369,387,599
 
15,504,409
 
77,341,177
 
Nancy Killefer
 
381,388,588
 
3,503,420
 
77,341,177
 
Susan J. Kropf
 
381,341,241
 
3,550,767
 
77,341,177
 
Helen McCluskey
 
380,658,335
 
4,233,673
 
77,341,177
 
Andrew G. McMaster, Jr.
 
383,519,143
 
1,372,865
 
77,341,177
 
 James A. Mitarotonda
 
382,549,408
 
2,342,600
 
77,341,177
 
Jan Zijderveld
 
383,535,240
 
1,356,768
 
77,341,177


2. The advisory vote on executive compensation was approved:

Votes For
 
Votes
Against
 
Abstentions
 
Broker
Non-Votes
358,501,200
 
26,018,509
 
372,299
 
77,341,177

3. The Company’s 2016 Omnibus Incentive Plan (Amended and Restated Effective May 16, 2019) was approved:
 
Votes For
 
Votes
Against
 
Abstentions
 
Broker
Non-Votes
370,782,463
 
13,698,975
 
410,570
 
77,341,177

4. The appointment of PricewaterhouseCoopers LLP, United Kingdom as the Company’s independent registered public accounting firm for 2019 was ratified:

Votes For
 
Votes
Against
 
Abstentions
460,909,042
 
1,032,266
 
291,877





Item 9.01.
Financial Statements and Exhibits.

 
(d)            Exhibits
 
Exhibit No.
 
Description





 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
AVON PRODUCTS, INC.
 
  (Registrant)
 
       

By:
 
     
   
Title:   Vice President, Interim General Counsel and
            Corporate Secretary
 
Date: May 17, 2019
     


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:5/17/19
For Period End:5/16/19DEF 14A
4/2/194,  8-K,  DEF 14A,  DEFA14A
 List all Filings 
Top
Filing Submission 0000950157-19-000609   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 5:49:01.2pm ET